| Adhesion molecules . | n . | D . | ||
|---|---|---|---|---|
| P1 . | P2 . | hypo-OS . | ||
| µm | µm | µm | ||
| VASP | 10 | 5.2 ± 1.3 | 0.8 ± 0.4** | – |
| Integrin-β3 | 10 | 4.4 ± 1.6 | 0.8 ± 0.6* | – |
| Paxillin | 12 | 4.0 ± 1.5 | 0.6 ± 0.3* | – |
| Talin | 10 | 5.4 ± 1.2 | 0.9 ± 0.5** | – |
| Zyxin | 11 | 5.0 ± 1.2 | 0.6 ± 0.4** | – |
| Vinculin | 12 | 4.7 ± 1.4 | 0.6 ± 0.4* | – |
| Paxillin + hypo-OS | 5 | 5.0 ± 1.3 | 1.1 ± 0.5* | 0.5 ± 0.3 |
| Paxillin + BBI | 5 | 3.7 ± 1.6 | 0.9 ± 0.6* | – |
| Paxillin + BBI + hypo-OS | 5 | 3.5 ± 1.9 | 0.6 ± 0.3* | 0.4 ± 0.3 |
| Adhesion molecules . | n . | D . | ||
|---|---|---|---|---|
| P1 . | P2 . | hypo-OS . | ||
| µm | µm | µm | ||
| VASP | 10 | 5.2 ± 1.3 | 0.8 ± 0.4** | – |
| Integrin-β3 | 10 | 4.4 ± 1.6 | 0.8 ± 0.6* | – |
| Paxillin | 12 | 4.0 ± 1.5 | 0.6 ± 0.3* | – |
| Talin | 10 | 5.4 ± 1.2 | 0.9 ± 0.5** | – |
| Zyxin | 11 | 5.0 ± 1.2 | 0.6 ± 0.4** | – |
| Vinculin | 12 | 4.7 ± 1.4 | 0.6 ± 0.4* | – |
| Paxillin + hypo-OS | 5 | 5.0 ± 1.3 | 1.1 ± 0.5* | 0.5 ± 0.3 |
| Paxillin + BBI | 5 | 3.7 ± 1.6 | 0.9 ± 0.6* | – |
| Paxillin + BBI + hypo-OS | 5 | 3.5 ± 1.9 | 0.6 ± 0.3* | 0.4 ± 0.3 |
Statistical analyses (t tests) were performed comparing D values in both P1 and P2 for each adhesion marker. *, P < 0.05; **, P < 0.01.